On average, TP53 mutations occur in 57% ( ± 15%) of African cases versus 29% of TCGA White tumours—a 28% increase, p < 0.001—while GATA3 mutations average 15% ( ± 2.8%) compared with 12% in the White cohort—a 3% increase, p = n.s.). The gene discussed is TP53; the disease is neoplasm.